Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 1
2010 3
2011 2
2012 3
2013 8
2014 2
2017 1
2018 3
2019 4
2020 3
2021 6
2022 9
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.
van den Bosch CH, Jeremiasse B, van der Bruggen JT, Frakking FNJ, Loeffen YGT, van de Ven CP, van der Steeg AFW, Fiocco MF, van de Wetering MD, Wijnen MHWA. van den Bosch CH, et al. Among authors: van de ven cp. J Hosp Infect. 2022 May;123:143-155. doi: 10.1016/j.jhin.2021.10.022. Epub 2021 Nov 9. J Hosp Infect. 2022. PMID: 34767871 Free article. Review.
Congenital diaphragmatic hernia: still a moving target.
Sluiter I, van de Ven CP, Wijnen RM, Tibboel D. Sluiter I, et al. Among authors: van de ven cp. Semin Fetal Neonatal Med. 2011 Jun;16(3):139-44. doi: 10.1016/j.siny.2011.03.002. Epub 2011 Apr 3. Semin Fetal Neonatal Med. 2011. PMID: 21463974 Review.
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
van den Bosch CH, Loeffen Y, van der Steeg AFW, van der Bruggen JT, Frakking FNJ, Fiocco M, van de Ven CP, Wijnen MHWA, van de Wetering MD. van den Bosch CH, et al. Among authors: van de ven cp. BMJ Open. 2023 Mar 21;13(3):e069760. doi: 10.1136/bmjopen-2022-069760. BMJ Open. 2023. PMID: 36944461 Free PMC article.
A Novel Standard for Systematic Reporting of Neuroblastoma Surgery: The International Neuroblastoma Surgical Report Form (INSRF): A Joint Initiative by the Pediatric Oncological Cooperative Groups SIOPEN∗, COG∗∗, and GPOH∗∗∗.
Matthyssens LE, Nuchtern JG, Van De Ven CP, Gabra HOS, Bjornland K, Irtan S, Stenman J, Pio L, Cross KM, Avanzini S, Inserra A, Chacon JG, Dall'igna P, Von Schweinitz D, Holmes K, Fuchs J, Squire R, Valteau-Couanet D, Park JR, Eggert A, Losty PD, La Quaglia MP, Sarnacki S; on behalf of the Surgical and Medical Committees of SIOPEN , COG and GPOH. Matthyssens LE, et al. Among authors: van de ven cp. Ann Surg. 2022 Mar 1;275(3):e575-e585. doi: 10.1097/SLA.0000000000003947. Ann Surg. 2022. PMID: 32649454
Strategy for management of newborns with cervical teratoma.
De Backer A, Madern GC, van de Ven CP, Tibboel D, Hazebroek FW. De Backer A, et al. Among authors: van de ven cp. J Perinat Med. 2004;32(6):500-8. doi: 10.1515/JPM.2004.122. J Perinat Med. 2004. PMID: 15576271 Review.
Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).
Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM. Gooskens SL, et al. Among authors: van de ven cp. Pediatr Blood Cancer. 2010 Aug;55(2):369-73. doi: 10.1002/pbc.22494. Pediatr Blood Cancer. 2010. PMID: 20582941 Review.
Intra- and inter-fraction uncertainties during IGRT for Wilms' tumor.
Guerreiro F, Seravalli E, Janssens GO, van de Ven CP, van den Heuvel-Eibrink MM, Raaymakers BW. Guerreiro F, et al. Among authors: van de ven cp. Acta Oncol. 2018 Jul;57(7):941-949. doi: 10.1080/0284186X.2018.1438655. Epub 2018 Feb 19. Acta Oncol. 2018. PMID: 29457751
47 results